Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer.
Funakoshi Y, Yakushijin K, Ohji G, Hojo W, Sakai H, Takai R, Nose T, Ohata S, Nagatani Y, Koyama T, Kitao A, Nishimura M, Imamura Y, Kiyota N, Harada K, Tanaka Y, Mori Y, Minami H. Funakoshi Y, et al. Among authors: nishimura m. J Infect Chemother. 2022 Apr;28(4):516-520. doi: 10.1016/j.jiac.2021.12.021. Epub 2021 Dec 30. J Infect Chemother. 2022. PMID: 35090826 Free PMC article.
L-Asparaginase-induced fulminating liver dysfunction.
Okamura A, Nishimura M, Sanada Y, Yakushijin K, Matsuoka H, Yamamoto K, Minami H. Okamura A, et al. Among authors: nishimura m. Int J Hematol. 2013 Jul;98(1):6-7. doi: 10.1007/s12185-013-1375-z. Epub 2013 May 24. Int J Hematol. 2013. PMID: 23702916 No abstract available.
The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer.
Nishimura M, Toyoda M, Takenaka K, Imamura Y, Chayahara N, Kiyota N, Mukohara T, Kotake T, Tsuji A, Saito K, Saito Y, Minami H. Nishimura M, et al. Cancer Chemother Pharmacol. 2016 Jun;77(6):1165-70. doi: 10.1007/s00280-016-3026-6. Epub 2016 Apr 21. Cancer Chemother Pharmacol. 2016. PMID: 27100735 Free PMC article.
Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging.
Nishimura M, Hayashi M, Mizutani Y, Takenaka K, Imamura Y, Chayahara N, Toyoda M, Kiyota N, Mukohara T, Aikawa H, Fujiwara Y, Hamada A, Minami H. Nishimura M, et al. Oncotarget. 2018 Apr 6;9(26):18540-18547. doi: 10.18632/oncotarget.24928. eCollection 2018 Apr 6. Oncotarget. 2018. PMID: 29719624 Free PMC article.
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.
Funakoshi Y, Yakushijin K, Ohji G, Hojo W, Sakai H, Watanabe M, Saeki M, Hirakawa Y, Sakai R, Matsumoto S, Mizutani Y, Kitao A, Miyata Y, Saito Y, Kawamoto S, Yamamoto K, Ito M, Nishimura M, Imamura Y, Kiyota N, Matsuoka H, Mori Y, Minami H. Funakoshi Y, et al. Among authors: nishimura m. Int J Hematol. 2022 Jan;115(1):7-10. doi: 10.1007/s12185-021-03247-y. Epub 2022 Jan 4. Int J Hematol. 2022. PMID: 34981433 Free PMC article.
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.
Aoyama Y, Ozaki Y, Kizawa R, Masuda J, Kawai S, Kurata M, Maeda T, Yoshida K, Yamashita N, Nishimura M, Hosonaga M, Fukada I, Hara F, Kobayashi T, Takano T, Ueno T. Aoyama Y, et al. Among authors: nishimura m. Breast Cancer. 2024 Dec 7. doi: 10.1007/s12282-024-01657-4. Online ahead of print. Breast Cancer. 2024. PMID: 39644440
4,525 results